» Articles » PMID: 19255021

Maternal Vitamin B12 Status and Risk of Neural Tube Defects in a Population with High Neural Tube Defect Prevalence and No Folic Acid Fortification

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2009 Mar 4
PMID 19255021
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Folic acid fortification has reduced neural tube defect prevalence by 50% to 70%. It is unlikely that fortification levels will be increased to reduce neural tube defect prevalence further. Therefore, it is important to identify other modifiable risk factors. Vitamin B(12) is metabolically related to folate; moreover, previous studies have found low B(12) status in mothers of children affected by neural tube defect. Our objective was to quantify the effect of low B(12) status on neural tube defect risk in a high-prevalence, unfortified population.

Methods: We assessed pregnancy vitamin B(12) status concentrations in blood samples taken at an average of 15 weeks' gestation from 3 independent nested case-control groups of Irish women within population-based cohorts, at a time when vitamin supplementation or food fortification was rare. Group 1 blood samples were from 95 women during a neural tube defect-affected pregnancy and 265 control subjects. Group 2 included blood samples from 107 women who had a previous neural tube defect birth but whose current pregnancy was not affected and 414 control subjects. Group 3 samples were from 76 women during an affected pregnancy and 222 control subjects.

Results: Mothers of children affected by neural tube defect had significantly lower B(12) status. In all 3 groups those in the lowest B(12) quartiles, compared with the highest, had between two and threefold higher adjusted odds ratios for being the mother of a child affected by neural tube defect. Pregnancy blood B(12) concentrations of <250 ng/L were associated with the highest risks.

Conclusions: Deficient or inadequate maternal vitamin B(12) status is associated with a significantly increased risk for neural tube defects. We suggest that women have vitamin B(12) levels of >300 ng/L (221 pmol/L) before becoming pregnant. Improving B(12) status beyond this level may afford a further reduction in risk, but this is uncertain.

Citing Articles

Biological, dietetic and pharmacological properties of vitamin B.

Siatka T, Matus M, Moravcova M, Harcarova P, Lomozova Z, Matousova K NPJ Sci Food. 2025; 9(1):30.

PMID: 40075081 PMC: 11904035. DOI: 10.1038/s41538-025-00396-w.


Double Fortified Salt Containing Iodine and Folic Acid and Triple Fortified Salt Containing Iodine, Folic Acid, and Vitamin B Are Acceptable to Ethiopian Women of Reproductive Age.

Tesfaye B, Tessema M, Arnold C, Kebebe T, Zeru T, Assefa T Food Sci Nutr. 2025; 13(1):e70012.

PMID: 39886523 PMC: 11780718. DOI: 10.1002/fsn3.70012.


Antiepileptic drugs, folate one-carbon metabolism, genetics, and epigenetics: Congenital, developmental, and neuropsychological risks and antiepileptic action.

Reynolds E Epilepsia. 2024; 65(12):3469-3473.

PMID: 39373638 PMC: 11647427. DOI: 10.1111/epi.18120.


Folate and Vitamin B12 Status in Women of Reproductive Age in Rural Haryana, India: Estimating Population-Based Prevalence for Neural Tube Defects.

Das R, Duggal M, Rosenthal J, Kankaria A, Senee H, Jabbar S Birth Defects Res. 2024; 116(8):e2390.

PMID: 39162364 PMC: 11373839. DOI: 10.1002/bdr2.2390.


National and regional population attributable fractions for anemia risk factors (iron, folate, and vitamin B12) in Belize: potential impact of fortification.

Rosenthal J, Alverson C, Largaespada-Beer N, Kauwell G, Bailey L, Sabido J Rev Panam Salud Publica. 2024; 48:e61.

PMID: 38974807 PMC: 11225218. DOI: 10.26633/RPSP.2024.61.


References
1.
Murphy J . Drugs and pregnancy. Ir Med J. 1984; 77(2):52-6. View

2.
Mills J, Signore C . Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol. 2004; 70(11):844-5. DOI: 10.1002/bdra.20075. View

3.
Czeizel A, Dudas I . Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992; 327(26):1832-5. DOI: 10.1056/NEJM199212243272602. View

4.
Troen A, Mitchell B, Sorensen B, Wener M, Johnston A, Wood B . Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2005; 136(1):189-94. DOI: 10.1093/jn/136.1.189. View

5.
Seller M . Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin Genet. 1988; 33(6):441-8. DOI: 10.1111/j.1399-0004.1988.tb03478.x. View